Neurology Archives - Page 4 of 11

Unmet needs of people with epilepsy: A qualitative study exploring their journey from presentation to long-term management across five European countries

Authors: E Graham-Rowe, C B Katzer, S Riaz, A Attwood, L Bates, R Sainz-Fuertes, B Swan Published: Frontiers in Neurology, 2023 View publication Introduction Epilepsy is a neurological disease that can negatively...

Patient-reported experiences with migraine-related cognitive symptoms: results of the MiCOAS qualitative study

Authors: M Gerstein, R J Wirth, A A Uzumcu, C R Houts, J S McGinley, D C Buse, K P McCarrier, A Cooke, N M Touba, T K Nishida, P J Goadsby,...

Variation in access to specialist services for neurosurgical procedures in adults with epilepsy in England, a cohort study

Authors: J Murphy, G C Hall, F Barion, V Danielson, M Dibué, J Wallace, M Alexander, S Beecroft, A Sen Published: Seizure, 2023 View publication Purpose To understand if primary consultation at...

Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review

Authors: P Jain, L Badgujar, J Spoorendonk & K Buesch Published: Therapeutic Advances in Rare Disease – SAGE Journal, 2022 View publication Objectives The rare inherited autosomal recessive disease Friedreich ataxia (FA)...

Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)

Authors: R J Aspinall, M Hudson, S D Ryder, P Richardson, E Farrington, M Wright, R T Przemioslo, F Perez, M Kent, R Henrar, J Hickey, D L Shawcross Published: Frontline Gastroenterology,...

Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer’s disease

Authors: R B Lipton, L Podger, W F Stewart, D Gomez-Ulloa, W I Rodriguez, M C Runken, F B Barnes, D Serrano Published: Expert Review of Neurotherapeutics, 2022 View publication Introduction Alzheimer’s...

Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands

Authors: M A Piena, M Heisen, L W Wormhoudt, J van Wingerden, S T F M Frequin, B M J Uitdehaag Published: Journal of Medical Economics, 2018 View publication Aim In active...

Impact of non-cardiac clinicopathologic characteristics on survival in transthyretin amyloid polyneuropathy

Authors: A González-Duarte, I Conceição, L Amass, M F Botteman, J A Carter, M Stewart Published: Neurology and Therapy, 2020 View publication Introduction Hereditary (variant) transthyretin amyloidosis (ATTRv) with polyneuropathy (ATTR-PN) is...

Effects of levodopa-carbidopa intestinal gel on dyskinesia and non-motor symptoms including sleep: results from a meta-analysis with 24-month follow-up

Authors: K Ray Chaudhuri, A Antonini, R Pahwa, P Odin, N Titova, S Thakkar, S J Snedecor, S Hegde, A Alobaidi, J C Parra, C Zadikoff, L Bergmann, D G Standaert Published:...

News